Cargando…

Early Colorectal Responses to HIV-1 and Modulation by Antiretroviral Drugs

Innate responses during acute HIV infection correlate with disease progression and pathogenesis. However, limited information is available about the events occurring during the first hours of infection in the mucosal sites of transmission. With an ex vivo HIV-1 challenge model of human colorectal ti...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrera, Carolina, McRaven, Mike D., Laing, Ken G., Dennis, Jayne, Hope, Thomas J., Shattock, Robin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000905/
https://www.ncbi.nlm.nih.gov/pubmed/33800213
http://dx.doi.org/10.3390/vaccines9030231
_version_ 1783671105433632768
author Herrera, Carolina
McRaven, Mike D.
Laing, Ken G.
Dennis, Jayne
Hope, Thomas J.
Shattock, Robin J.
author_facet Herrera, Carolina
McRaven, Mike D.
Laing, Ken G.
Dennis, Jayne
Hope, Thomas J.
Shattock, Robin J.
author_sort Herrera, Carolina
collection PubMed
description Innate responses during acute HIV infection correlate with disease progression and pathogenesis. However, limited information is available about the events occurring during the first hours of infection in the mucosal sites of transmission. With an ex vivo HIV-1 challenge model of human colorectal tissue we assessed the mucosal responses induced by R5- and X4-tropic HIV-1 isolates in the first 24 h of exposure. Microscopy studies demonstrated virus penetration of up to 39 μm into the lamina propia within 6 h of inoculation. A rapid, 6 h post-challenge, increase in the level of secretion of inflammatory cytokines, chemokines, interferon- γ (IFN-γ), and granulocyte-macrophage colony-stimulating factor (GM-CSF) was observed following exposure to R5- or X4-tropic isolates. This profile persisted at the later time point measured of 24 h. However, exposure to the X4-tropic isolate tested induced greater changes at the proteomic and transcriptomic levels than the R5-tropic. The X4-isolate induced greater levels of CCR5 ligands (RANTES, MIP-1α and MIP-1β) secretion than R5-HIV-1. Potential drugs candidates for colorectal microbicides, including entry, fusion or reverse transcriptase inhibitors demonstrated differential capacity to modulate these responses. Our findings indicate that in colorectal tissue, inflammatory responses and a Th1 cytokine profile are induced in the first 24 h following viral exposure.
format Online
Article
Text
id pubmed-8000905
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80009052021-03-28 Early Colorectal Responses to HIV-1 and Modulation by Antiretroviral Drugs Herrera, Carolina McRaven, Mike D. Laing, Ken G. Dennis, Jayne Hope, Thomas J. Shattock, Robin J. Vaccines (Basel) Article Innate responses during acute HIV infection correlate with disease progression and pathogenesis. However, limited information is available about the events occurring during the first hours of infection in the mucosal sites of transmission. With an ex vivo HIV-1 challenge model of human colorectal tissue we assessed the mucosal responses induced by R5- and X4-tropic HIV-1 isolates in the first 24 h of exposure. Microscopy studies demonstrated virus penetration of up to 39 μm into the lamina propia within 6 h of inoculation. A rapid, 6 h post-challenge, increase in the level of secretion of inflammatory cytokines, chemokines, interferon- γ (IFN-γ), and granulocyte-macrophage colony-stimulating factor (GM-CSF) was observed following exposure to R5- or X4-tropic isolates. This profile persisted at the later time point measured of 24 h. However, exposure to the X4-tropic isolate tested induced greater changes at the proteomic and transcriptomic levels than the R5-tropic. The X4-isolate induced greater levels of CCR5 ligands (RANTES, MIP-1α and MIP-1β) secretion than R5-HIV-1. Potential drugs candidates for colorectal microbicides, including entry, fusion or reverse transcriptase inhibitors demonstrated differential capacity to modulate these responses. Our findings indicate that in colorectal tissue, inflammatory responses and a Th1 cytokine profile are induced in the first 24 h following viral exposure. MDPI 2021-03-08 /pmc/articles/PMC8000905/ /pubmed/33800213 http://dx.doi.org/10.3390/vaccines9030231 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Article
Herrera, Carolina
McRaven, Mike D.
Laing, Ken G.
Dennis, Jayne
Hope, Thomas J.
Shattock, Robin J.
Early Colorectal Responses to HIV-1 and Modulation by Antiretroviral Drugs
title Early Colorectal Responses to HIV-1 and Modulation by Antiretroviral Drugs
title_full Early Colorectal Responses to HIV-1 and Modulation by Antiretroviral Drugs
title_fullStr Early Colorectal Responses to HIV-1 and Modulation by Antiretroviral Drugs
title_full_unstemmed Early Colorectal Responses to HIV-1 and Modulation by Antiretroviral Drugs
title_short Early Colorectal Responses to HIV-1 and Modulation by Antiretroviral Drugs
title_sort early colorectal responses to hiv-1 and modulation by antiretroviral drugs
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000905/
https://www.ncbi.nlm.nih.gov/pubmed/33800213
http://dx.doi.org/10.3390/vaccines9030231
work_keys_str_mv AT herreracarolina earlycolorectalresponsestohiv1andmodulationbyantiretroviraldrugs
AT mcravenmiked earlycolorectalresponsestohiv1andmodulationbyantiretroviraldrugs
AT laingkeng earlycolorectalresponsestohiv1andmodulationbyantiretroviraldrugs
AT dennisjayne earlycolorectalresponsestohiv1andmodulationbyantiretroviraldrugs
AT hopethomasj earlycolorectalresponsestohiv1andmodulationbyantiretroviraldrugs
AT shattockrobinj earlycolorectalresponsestohiv1andmodulationbyantiretroviraldrugs